Gymnema sylvestre

Gymnema sylvestre is a plant native to India used for centuries in Ayurvedic medicine for its potential effects on blood sugar control. Its leaves contain active compounds called gymnemic acids, which have attracted scientific interest for their ability to modulate intestinal glucose absorption, improve certain metabolic parameters, and, in some cases, reduce cravings for sweet flavors.

In recent decades, several clinical trials have evaluated its efficacy and safety in people with type 2 diabetes, prediabetes, or metabolic syndrome, with results positioning it as a potential supplement within a comprehensive glycemic control plan, always under medical supervision.

How does it work?

• Partial blockage of sugar absorption: Gymnemic acids bind to intestinal receptors, hindering glucose entry into the bloodstream after meals.
• Sweet taste modulation: By interacting with taste receptors on the tongue, it can temporarily reduce the perception of sweetness and decrease the intake of simple sugars.
• Possible stimulation of pancreatic function: Some studies suggest it may promote insulin release, although human evidence is preliminary and should be interpreted with caution.

Benefits according to science

Type 2 Diabetes

Baskaran and colleagues (1990) conducted a study on 22 people with type 2 diabetes who were already taking oral medication. Over 18–20 months, they added 400 mg daily of standardized Gymnema sylvestre extract to their treatment. The group taking Gymnema significantly reduced fasting glucose, HbA1c, and in some cases, were able to reduce or discontinue medication under medical supervision.

Metabolic Syndrome

Zúñiga and his team in 2017 conducted a randomized, double-blind, placebo-controlled clinical trial in 24 non-medicated adults with metabolic syndrome. For 12 weeks, the administration of 600 mg daily of standardized extract reduced weight, body mass index, triglycerides, and VLDL cholesterol, with no significant changes in insulin sensitivity.

Prediabetes (glucose intolerance)

In a randomized, double-blind, placebo-controlled clinical trial, Gaytán Martínez and collaborators (2021) studied 30 people with glucose intolerance. They took 300 mg of extract twice daily for 12 weeks. At the end, significant reductions in postprandial glucose, HbA1c, and an improvement in insulin sensitivitywere observed, with no serious adverse effects reported.

Reduction in sweet consumption

More recently, Hsiao and colleagues in 2025 evaluated individuals with high sugar consumption in a 14-day crossover study. Participants used oral lozenges with gymnemic acid before consuming sweet foods. Consumption of sugary drinks decreased by 42%, cravings by 28%, and the "pleasantness" of sweet taste, with a temporary effect lasting between 30 and 60 minutes.

Dosage and forms of consumption

• For glycemic control and metabolic profile: 600 mg/day of standardized extract (300 mg before breakfast and 300 mg before dinner) for at least 12 weeks.
• For temporary reduction of sweet consumption: oral lozenges with gymnemic acid-rich extract, just before eating sugary foods (temporary effect).
• Format: capsules, tablets, or oral lozenges with standardized dry extract.

Safety and potential adverse effects

• Generally well-tolerated at usual doses.
• May potentiate the effect of antidiabetic medications, increasing the risk of hypoglycemia; blood glucose monitoring and dose adjustment under medical supervision are recommended.
• Rare side effects: mild digestive discomfort (nausea, diarrhea).
• Not recommended for use during pregnancy or breastfeeding without professional evaluation.

Conclusions

Gymnema sylvestre has several clinical trials supporting its potential as a supplement for improving glucose control, optimizing some metabolic parameters, and, acutely, reducing the craving and consumption of sweet foods.

Its evidence, although limited, is consistent and shows a favorable safety profile in healthy adults. It does not replace medical treatment and should be integrated into a supervised health plan that includes a balanced diet and exercise.

References

1. Baskaran, K., Ahamath, B. K., Shanmugasundaram, K. R., & Shanmugasundaram, E. R. B. (1990). Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. Journal of Ethnopharmacology, 30(3), 295–305. https://doi.org/10.1016/0378-8741(90)90108-6>
2. Gaytán Martínez LA, Sánchez-Ruiz LA, Zuñiga LY, González-Ortiz M, Martínez-Abundis E. Effect of Gymnema sylvestre Administration on Glycemic Control, Insulin Secretion, and Insulin Sensitivity in Patients with Impaired Glucose Tolerance. J Med Food. 2021 Jan;24(1):28-32. doi: 10.1089/jmf.2020.0024. Epub 2020 May 27. PMID: 32460589.
3. Zuñiga LY, González-Ortiz M, Martínez-Abundis E. Effect of Gymnema sylvestre Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion. J Med Food. 2017 Aug;20(8):750-754. doi: 10.1089/jmf.2017.0001. Epub 2017 May 1. PMID: 28459647.
4. Wh H, R K, C D, I N, E S, A A. The effect of a 14-day Gymnema sylvestre intervention to reduce sugar intake in people self-identifying with a sweet tooth. Appetite. 2025 Mar 1;207:107871. doi: 10.1016/j.appet.2025.107871. Epub 2025 Jan 23. PMID: 39855349.